First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.02 USD -0.97% Market Closed
Updated: Jun 9, 2024

Adaptimmune Therapeutics PLC
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adaptimmune Therapeutics PLC
PP&E Net Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
PP&E Net
$67.7m
CAGR 3-Years
14%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
PP&E Net
$13m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
PP&E Net
$95.7m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
PP&E Net
$24.8m
CAGR 3-Years
58%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
PP&E Net
£42.7m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
PP&E Net
£509.5m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
7%

See Also

What is Adaptimmune Therapeutics PLC's PP&E Net?
PP&E Net
67.7m USD

Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's PP&E Net amounts to 67.7m USD.

What is Adaptimmune Therapeutics PLC's PP&E Net growth rate?
PP&E Net CAGR 5Y
2%

Over the last year, the PP&E Net growth was -6%. The average annual PP&E Net growth rates for Adaptimmune Therapeutics PLC have been 14% over the past three years , 2% over the past five years .